The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock

Peer Review reports

Original Submission
16 Jul 2023	Submitted	Original manuscript
20 Aug 2023	Reviewed	Reviewer Report - Muslim Syed
10 Oct 2023	Reviewed	Reviewer Report - Frank Bloos
15 Oct 2023	Reviewed	Reviewer Report - Razvan Azamfirei
15 Oct 2023	Reviewed	Reviewer Report - Milind Bhagat
26 Dec 2023	Author responded	Author comments - J. Pedro Teixeira
Resubmission - Version 2
26 Dec 2023	Submitted	Manuscript version 2
28 Dec 2023	Reviewed	Reviewer Report - Muslim Syed
2 Jan 2024	Reviewed	Reviewer Report - Frank Bloos
2 Jan 2024	Reviewed	Reviewer Report - Razvan Azamfirei
7 Feb 2024	Author responded	Author comments - J. Pedro Teixeira
Resubmission - Version 3
7 Feb 2024	Submitted	Manuscript version 3
Publishing
20 Feb 2024	Editorially accepted
12 Mar 2024	Article published	10.1186/s13063-024-07995-0

Back to article page